Literature DB >> 27206757

Gabapentin and pregabalin for the treatment of chronic pruritus.

Kazuki M Matsuda1, Divya Sharma2, Ariel R Schonfeld3, Shawn G Kwatra4.   

Abstract

Chronic pruritus is a distressing symptom that is often refractory to treatment. Patients frequently fail topical therapies and oral over-the-counter antihistamines, prompting the clinician to consider alternative therapies such as neuroactive agents. Herein, the use of gabapentin and pregabalin, 2 medications well known for treating neuropathic pain and epilepsy that are occasionally used for relieving chronic pruritus is explored. The findings from original sources published to date to evaluate the use of gabapentin and pregabalin as antipruritic agents are explored. They are found to be promising alternative treatments for the relief of several forms of chronic pruritus, particularly uremic pruritus and neuropathic or neurogenic itch, in patients who fail conservative therapies.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  gabapentin; itch; neurogenic itch; neuropathic itch; pregabalin; pruritus; uremic pruritus

Mesh:

Substances:

Year:  2016        PMID: 27206757     DOI: 10.1016/j.jaad.2016.02.1237

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

Review 1.  Diagnosis and treatment of pruritus.

Authors:  Dominik A Nowak; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

Review 2. 

Authors:  Dominik Nowak; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

Review 3.  Comprehensive Review of Topical Analgesics for Chronic Pain.

Authors:  Jillian Maloney; Scott Pew; Christopher Wie; Ruchir Gupta; John Freeman; Natalie Strand
Journal:  Curr Pain Headache Rep       Date:  2021-02-03

Review 4.  Gabapentinoids for Pruritus in Older Adults: A Narrative Review.

Authors:  Shreya A Sreekantaswamy; Nicholas Mollanazar; Daniel C Butler
Journal:  Dermatol Ther (Heidelb)       Date:  2021-03-15

5.  Interventions for chronic pruritus of unknown origin.

Authors:  Andrea Andrade; Chii Yang Kuah; Juliana Esther Martin-Lopez; Shunjie Chua; Volha Shpadaruk; Gloria Sanclemente; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2020-01-25

6.  IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies.

Authors:  D M Barrios; G S Phillips; A N Geisler; S R Trelles; A Markova; S J Noor; E A Quigley; H C Haliasos; A P Moy; A M Schram; J Bromberg; S A Funt; M H Voss; A Drilon; M D Hellmann; E A Comen; S Narala; A B Patel; M Wetzel; J Y Jung; D Y M Leung; M E Lacouture
Journal:  Ann Oncol       Date:  2021-03-03       Impact factor: 51.769

7.  Riboflavin Inhibits Histamine-Dependent Itch by Modulating Transient Receptor Potential Vanilloid 1 (TRPV1).

Authors:  Kihwan Lee; Young In Choi; Sang-Taek Im; Sung-Min Hwang; Han-Kyu Lee; Jay-Zoon Im; Yong Ho Kim; Sung Jun Jung; Chul-Kyu Park
Journal:  Front Mol Neurosci       Date:  2021-06-18       Impact factor: 5.639

Review 8.  A New Generation of Treatments for Itch.

Authors:  Emilie Fowler; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

9.  Temperature Sensitivity After Burn Injury: A Burn Model System National Database Hot Topic.

Authors:  Jamie Oh; Christopher Madison; Grace Flott; Elisha G Brownson; Stephen Sibbett; Carolina Seek; Gretchen J Carrougher; Colleen M Ryan; Karen Kowalske; Nicole S Gibran; Barclay T Stewart
Journal:  J Burn Care Res       Date:  2021-11-24       Impact factor: 1.819

Review 10.  Pain management in hidradenitis suppurativa and a proposed treatment algorithm.

Authors:  Kevin T Savage; Vinita Singh; Zarine S Patel; Christine A Yannuzzi; Anne Marie McKenzie-Brown; Michelle A Lowes; Lauren A V Orenstein
Journal:  J Am Acad Dermatol       Date:  2020-09-17       Impact factor: 15.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.